Recent Developments in the Formulation of Nanoliposomal Delivery Systems

Author(s): Mandeep Dahiya, Harish Dureja*

Journal Name: Current Nanomaterials

Volume 3 , Issue 2 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Nanoliposomes, or submicron bilayer phospholipid vesicles, are a novel tool to encapsulate and deliver the active pharmaceutical ingredients. The listing of active substances for integration into nanoliposomes is enormous, varying from pharmaceuticals to nutraceuticals and cosmetics. Due to their biocompatible and biodegradable nature, besides their nanosize, nanoliposomes have applications in diverse areas, like cancer nanotherapy, cosmetics, gene delivery and agricultural food technology. Nanoliposomes have the capability of improving the efficacy of active agents by recuperating there in vitro-in vivo solubility, bioavailability, stability and prevent unnecessary interactions between molecules. Targeting by nanoliposomes depends on the types of the cells to achieve active drug concentrations for favorable therapeutic effectiveness at the desired target site and minimizing undesirable effects on healthy tissues and cells. This article sums up the existing studies that have described the nanoliposomal particles as carriers to transport a variety of pharmaceutical agents, properties, methods of preparation, and analysis.

Keywords: Docetaxel, doxorubicin, gene delivery, magnetic, nanoliposome, PEG, tumor.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [62 - 74]
Pages: 13
DOI: 10.2174/2405461503666180821093033

Article Metrics

PDF: 26